Latest Safety News

Bannerman Energy advances Etango uranium project with early works on track and CNNC Overseas Limited investment nearing completion, targeting a positive Final Investment Decision in Q3 2026.

Nyrada has dosed the first patient in its Phase IIa trial of Xolatryp targeting heart attack recovery, while strengthening its cash reserves and receiving a US patent allowance for its lead drug.

Imricor Medical Systems has officially launched its US commercial operations, securing Rady Children’s Hospital–San Diego as the first customer for its NorthStar iMR mapping system, following key FDA clearances including pediatric approvals.

Metals X reported a steady tin output at Renison with a 5.9% tin price lift boosting revenue and EBITDA despite increased costs and a marginal net cash flow dip. Capital projects and exploration advanced, while the company’s strong cash reserves underpin its growth ambitions.

Stanmore Resources bounced back from early-year weather disruptions with a 27% jump in ROM coal production in Q2 2026 and secured a refinancing deal that lowers debt costs and extends maturities, positioning the company for a robust second half.

Patrys Limited is pushing forward with a proprietary injectable formulation of quetiapine targeting the lucrative delirium treatment market, leveraging a faster, lower-cost FDA 505(b)(2) regulatory pathway and strong patent protection.

Hastings Technology Metals has accelerated its downstream rare earths strategy by progressing a 49% stake in a Thai hydrometallurgical plant, securing feedstock and doubling planned capacity. An updated Yangibana DFS reveals robust economics, underpinning near-term production and cash flow.

Critical Resources identified 14 pegmatite bodies at Mavis Lake’s Corona Field and confirmed high-grade tungsten and gold systems in New Zealand, while progressing its solid-state lithium-ion battery technology to full-format pouch cells.

EBR Systems has launched the WiSE Coupler in the US, a new accessory designed to improve the implantation of its wireless cardiac pacing electrode. The device has FDA clearance and was piloted in 10 procedures, marking another step in the company’s US commercial expansion.

X2M Connect has secured $2 million in a placement to boost its data centre and AI energy management platform, with a fully underwritten $1 million Securities Purchase Plan to follow. The capital raise supports sensor integration, platform enhancements, and battery energy systems aimed at cutting data centre precinct energy costs by up to 20%.

Argenica Therapeutics is gearing up for a pivotal late-stage clinical trial of its neuroprotective drug ARG-007 (xaranetide) in acute ischaemic stroke, backed by strong safety assays and solid funding.

Meteoric Resources has significantly boosted its Caldeira Rare Earth Project with a 246% increase in Measured Resources and pilot plant recoveries surpassing pre-feasibility targets, backed by a $40 million capital raise and advancing environmental approvals.